High-dose caffeine and cardiac rate and rhythm in normal subjects.
In a previous 24-hour study of the electrophysiologic effects of moderate dose caffeine (1 mg/kg body weight/half-life), we found a significant (p less than 0.01) increase in ventricular ectopic beat (VEB) frequency among 18 patients with preexisting primary ventricular dysrhythm (mean 207 +/- 350 VEBs/hour, no caffeine, versus 307 +/- 414 VEBs/hour, caffeine). We also found a statistically insignificant (NS) increase in the incidence of infrequent VEBs in 18 normal control subjects (four of 18, no caffeine vs nine of 18 caffeine). Because of the high risk of beta-error among the previously-studied normal control subjects, we tested another group of 34 normal subjects, 15 males and 19 females with a mean age of 31 years (range 21 to 49 years), using a higher dose of caffeine. All subjects abstained from caffeine for 72 hours and had a control 24-hour Holter ECG recorded between hours 48 and 72. Caffeine half-life was calculated for each subject and caffeine was then ingested at 1 mg/kg every 0.5 half-life during all waking hours. A 24-hour Holter test was recorded, beginning just prior to the second caffeine dose. It was concluded that in normal adults, even high-dose caffeine does not affect prevailing cardiac rhythm and rate, and moreover, does not cause clinically significant ventricular or supraventricular dysrhythm.
Newcombe
P F
PF
Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Renton
K W
KW
Rautaharju
P M
PM
Spencer
C A
CA
Montague
T J
TJ
D000328:Adult; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D002110:Caffeine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000633:toxicity*; D005117:Cardiac Complexes, Premature / Q000139:chemically induced; D003069:Coffee; D004562:Electrocardiography; D005260:Female; D006207:Half-Life; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic
D003069:Coffee; D002110:Caffeine